1. Home
  2. Browse
  3. National Institutes of Health
  4. PAR-24-311

PAR-24-311National Institutes of HealthR01

Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)

Deadline
Award ceiling
$500,000
Awards
Not stated
Posted
Nov 6, 2024

Official announcement on the NIH Guide · opens the funder's page. Always confirm dates there.

Or read the full text and all 3 review criteria here, free with an account. Create free account

Summary

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites research grant applications (R01) for the development and application of current and emerging molecular imaging methods to gain fundamental insights into cancer inflammation in vivo…

Related NIH announcements3

Other open R01 announcements on related subjects, with at least two weeks to go.

NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)

PAR-25-271National Institutes of Health3 review criteria on file

—

Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)

PAR-25-336National Institutes of Health4 review criteria on file

—

INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed)

RFA-OD-27-004National Institutes of Health3 review criteria on fileagency framework

$500k

The full announcement, free with an account

  • The full announcement text, not just the first two sentences
  • All 3 review criteria reviewers score this against, extracted from this announcement

On Plus, $39 a month

  • The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
  • Funded precedents: what similar NIH projects received, from the award records in NIH RePORTER
  • A Reviewer Scorecard of your draft against these criteria
Create free accountSign in

No card required. Browsing is free.

Subjects

More from National Institutes of Health

Open now with at least two weeks to apply, soonest deadline first.

NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

PAR-25-057National Institutes of Health6 review criteria on file

—

Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)

RFA-DK-27-108National Institutes of Health3 review criteria on fileagency framework

$500k

Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)

RFA-DK-27-139National Institutes of Health

—

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

RFA-DK-27-112National Institutes of Health

—

Everything open from National Institutes of Health

Related by subject

Open opportunities sharing the most subjects with this one (Cancer, Immunology), with at least two weeks to apply.

Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional)

PAR-27-015National Institutes of Health3 review criteria on file

$300k

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

RFA-CA-27-001National Institutes of Health4 review criteria on file

$150k

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

RFA-CA-27-002National Institutes of Health4 review criteria on fileagency framework

$300k

Everything open tagged Cancer

Hiring in this research area now

All immunology jobs

Source record: https://grants.nih.gov/grants/guide/pa-files/PAR-24-311.htmlVia the NIH Guide. Last checked against the source . Always confirm dates with the funder.